{"entity":{"id":"competing-risks","kind":"term","name":"Competing events and cumulative incidence","aka":["competing risks","cause-specific hazard and cumulative incidence"],"tldr":"One event can prevent another outcome from being observed. A cancer study needs to explain how it handles such events when estimating the chance of an outcome.","summary":"For a recurrence outcome, death before recurrence may be a competing event; another endpoint may count death as part of a composite instead. Methodological work using relapse and non-relapse mortality illustrates why a cause-specific event rate and cumulative event probability answer different questions. Treating competing events as ordinary censoring can distort the estimated probability. Interpretation depends on the endpoint definition and analysis, rather than the name of the survival curve alone.","asOf":"2026-11-08","links":[{"label":"Competing-risk methodology with transplantation illustration (2012)","url":"https://doi.org/10.1093/ije/dyr213"}],"tags":[],"related":["other-cause-mortality","estimand","kaplan-meier-curve"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Endpoints"},"route":"/terms/competing-risks/","neighbours":{"term":[{"id":"estimand","kind":"term","name":"Estimands and intercurrent events (ICH E9(R1))","route":"/terms/estimand/"},{"id":"measurement-to-benefit-evidence","kind":"term","name":"Evidence from measurement to patient benefit","route":"/terms/measurement-to-benefit-evidence/"},{"id":"kaplan-meier-curve","kind":"term","name":"Kaplan-Meier curve, censoring and proportional hazards","route":"/terms/kaplan-meier-curve/"},{"id":"other-cause-mortality","kind":"term","name":"Other-cause mortality","route":"/terms/other-cause-mortality/"}]}}